A glucose-lowering drug can protect kidneys in type 1 diabetes patients
Dapagliflozin, can protect the kidneys in patients with type 1 diabetes. According to results shown in a new study published in the Lancet.
Close to 17 percent of patients recovered from COVID-19 could still carry virus
Although meeting the criteria for discontinuation of quarantine, patients with persistent respiratory symptoms are more likely to test positive for the virus, finds a new study in the…
Gut symptoms and low mood may be linked to a later diagnosis of inflammatory bowel disease
A new study, published in Gut, has found depression is more common among people with Crohn’s disease or ulcerative colitis in the years before they are diagnosed with…
More than 40% of women suffer from constipation during pregnancy and right after childbirth
Women are 2–3 times more likely to suffer from constipation during pregnancy and right after childbirth than at any other time in their life, a new study from…
Ten or more medications, often prescribed to older heart failure patients, raises concerns Source: American Heart Association
More than half of older patients hospitalized for heart failure are discharged from the hospital with prescriptions for 10 or more medications, according to new research published today…